| California Pacific Medical Center-st Luke's Campus Hospital | |
|
3555 Cesar Chavez San Francisco CA 94110-4403 | |
| (415) 647-8600 | |
| Not Available |
| Full Name | California Pacific Medical Center-st Luke's Campus Hospital |
|---|---|
| Speciality | Clinic/center |
| Location | 3555 Cesar Chavez, San Francisco, California |
| Authorized Official Name and Position | John Gates (VICE PRESIDENT OF ADMIN CFO) |
| Authorized Official Contact | 4156003959 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| California Pacific Medical Center-st Luke's Campus Hospital 3555 Cesar Chavez San Francisco CA 94110-4403 Ph: (415) 647-8600 | California Pacific Medical Center-st Luke's Campus Hospital 3555 Cesar Chavez San Francisco CA 94110-4403 Ph: (415) 647-8600 |
| NPI Number | 1043338957 |
|---|---|
| Provider Enumeration Date | 03/27/2007 |
| Last Update Date | 01/07/2022 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043338957 | NPI | - | NPPES |
| HSP40055G | Medicaid | CA | |
| HSP40055F | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 220000070 (California) | Primary |
News Archive
Gabapentin, a drug initially used to treat seizures, improves sleep quality in menopausal women with hot flashes, University of Rochester Medical Center researchers report online and in the September issue of the Journal of Women's Health.
Cameron Health, Inc. announced today that it has completed enrollment in its pivotal FDA clinical study of the S-ICD System, the world's only completely subcutaneous implantable defibrillator.
AFFiRiS AG will focus its Alzheimer's vaccine program on one product candidate at an unexpectedly early stage of development: the vaccine candidate AD02 is planned to enter into Phase II clinical trial early in 2010. This decision by the company immediately follows the completion of two Phase I trials with the candidates AD01 and AD02. The company based its fast decision on the first interim analysis of the secondary endpoints at the six month time point.
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Phase 2 data of KRX-0401 (perifosine), the Company's PI3K/Akt pathway inhibitor for cancer, as a single agent in the treatment of advanced metastatic renal cell cancer, has been selected for oral presentation at the Eighth International Kidney Cancer Symposium, to be held in Chicago from September 25-26, 2009.
› Verified 2 days ago
Richard Joseph Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 548 Market St # 50727, San Francisco, CA 94104 Phone: 415-851-3224 | |
James Y.greenberg, Md, A Professional Corporation Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2299 Post St Ste 205, San Francisco, CA 94115 Phone: 415-474-7955 Fax: 415-292-0718 | |
Inpatient Services Of California, Inc., A Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3555 Cesar Chavez St, San Francisco, CA 94110 Phone: 415-641-6401 | |
Jew & Jew Medical Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 919 Clay St, San Francisco, CA 94108 Phone: 415-982-4011 Fax: 415-982-6291 | |
Hampton Health Ltd Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1700 California St, Ste. 470, San Francisco, CA 94109 Phone: 415-202-9990 Fax: 415-843-0548 | |
North East Medical Services-leland Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 82 Leland Avenue, San Francisco, CA 94134 Phone: 415-391-9686 Fax: 415-333-9067 | |
Mission Area Health Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1580 Valencia St Ste 506, San Francisco, CA 94110 Phone: 415-852-4080 Fax: 415-431-3178 |